Skip to main content
logo
Jasper Therapeutics, Inc. (JSPR)
NASDAQ: JSPR · Real-Time Price · USD
0.7224
+0.0064 (0.89%)
At close: Aug 24, 2026, 4:00 PM EDT
0.7085
-0.0139 (-1.92%)
After-hours: Aug 24, 2026, 5:07 PM EDT

Jasper Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
24513218822389
Market Cap Growth
-48.11%-84.03%264.33%294.73%-94.26%210.66%
Enterprise Value
172230-13-25291
Last Close Price
0.721.8321.387.894.8378.50

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
14.2312.345.201.120.625.59
P/TBV Ratio
16.1312.345.201.120.625.59

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.190.300.030.040.100.04
Net Debt / Equity Ratio
-4.99-6.61-1.13-1.07-0.96-1.18
Net Debt / EBITDA Ratio
0.140.340.931.240.692.24
Net Debt / FCF Ratio
0.120.361.111.610.752.27
Quick Ratio
0.932.174.707.045.5410.63
Current Ratio
1.482.634.977.195.9110.95
Return on Equity (ROE)
-255.05%-230.31%-101.73%-112.67%-71.44%-78.33%
Return on Assets (ROA)
-113.41%-88.16%-54.52%-60.09%-45.06%-39.35%
Return on Capital Employed (ROCE)
-1336.00%-361.30%-117.90%-83.40%-124.00%-43.00%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-139.39%-148.02%-22.22%-73.23%-168.98%-7.88%
FCF Yield
-264.70%-150.69%-19.69%-59.45%-208.21%-9.29%
Buyback Yield / Dilution
-71.73%-31.42%-39.72%-186.15%-220.19%-558.67%
SEC Filings: 10-K · 10-Q